Online edition of India's National Newspaper
Saturday, April 28, 2001

Front Page | National | Southern States | Other States | State Elections | International | Opinion | Business | Sport | Miscellaneous | Features | Classifieds | Employment | Index | Home

Business | Previous | Next

Gujarat Ambuja Cements net up 32 p.c.

Gujarat Ambuja Cements has posted a net profit of Rs. 65.69 crores for the third quarter ended March 31, 2001 against Rs 49.90 crores an increase of 32 per cent over the corresponding period last year.

During the third quarter, it sold 15.42 lakh tonne of cement against 14.98 lakh tonne in the same period last year. The turnover during the period was Rs. 386.25 crores against Rs. 331.48 crores, an increase of 17 per cent.

The operating profit is up by 27 per cent at Rs. 132.02 crores against Rs. 103.61 crores in the previous year. The net profit has been arrived after charging an interest of Rs. 31.95 crores against Rs. 22.81 crores in the same period last year. The depreciation was Rs. 34.38 crores against Rs. 30.90 crores.

``The Company has commissioned its half million tonne cement grinding unit at Bhatinda, Punjab,'' stated a press release issued by Ambuja Cement. With the commissioning of this unit, the company will be able to cater to South Punjab market. Work on its two million tonne cement plant at Chandrapur, Maharashtra is progressing fast and Company expects to complete the cement project on schedule in December 2001.

Exide Industries

Exide Industries has announced a lower net profit of Rs. 41.50 crores for the year ended March 2001 against Rs. 48.89 crores in the previous year. In spite of this, the company has announced a dividend of 40 per cent, including an interim dividend of 25 per cent made earlier.

Turnover for the year was marginally higher at Rs. 954 crores against Rs. 939 crores. Net sales were at Rs. 770 crores against Rs. 752 crores. The operating profit was Rs. 140.80 crores against Rs. 146 crores.

The dividend has been declared keeping in mind the future prospects and the company's healthy reserves position, according to a company press release.

According to the chairman, Mr S. B. Ganguly, the results reflected the company's concerns over the liberalised import regime that has left an uneven playing field for the indigenous battery industry. He hoped the government would take a positive view on `anomalous' customs duty structure on raw materials and finished products.

Glaxo

Glaxo India has reported a 27.87 per cent decline in net profit at Rs. 10.17 crores for the first quarter ended March 31, 2001 against Rs. 14.10 crores in same period of previous fiscal.

Net sales have risen marginally to Rs. 194.36 crores from Rs. 183.24 crores. Other income accounted for Rs. 63.70 crores (Rs. 80 crores).

Interest charges have risen to Rs. 2.27 crores (Rs. 2.08 crores). Depreciation claims Rs. 3.78 crores (Rs. 3.93 crores).

The profit before tax has grown by 12.3 per cent against net sales growth of 6.1 per cent, after excluding profit on sale of brands, income from investments/property rentals and expenses on restructuring/integration pursuant to the proposed amalgamation of Smithkline Beecham Pharmaceuticals India with the company.

Cipla

Cipla has announced a net profit of Rs. 178.42 crores for the year ended March 2001 against Rs. 133.06 crores in the previous year. Net sales were higher at Rs. 1,047.65 crores against Rs. 759.75 crores. Other income amounted to Rs. 39.60 crores (Rs. 35.74 crores). The company provided Rs. 91 lakhs (Rs. 1.14 crores) for interest, Rs. 15.50 crores (Rs. 13.34 crores) for depreciation and Rs. 60.50 crores (Rs. 39.60 crores) for tax. During the year, exports jumped by 84 per cent to Rs. 258 crores (Rs. 140 crores).

For the fourth quarter ended March 2001, the company reported a net profit of Rs. 34.36 crores (Rs. 29.08 crores) on a net sales of Rs. 260.56 crores (Rs. 172.10 crores). Other income amounted to Rs. 13.86 crores (Rs. 11.76 crores). The company provided Rs. 9 lakhs (Rs. 13 crores) for interest, Rs. 3.25 crores (Rs. 2.50 crores) for depreciation and Rs. 11 crores (Rs. 3.75 crores) for tax.

Cadbury

Cadbury India has declared a net profit of Rs. 12.39 crores in the first three months ended March 31, 2001 against Rs. 10.50 crores. Despite sluggish market conditions the company grew both in domestic and exports market. Net sales were higher at Rs.149.91 crores against Rs. 139.34 crores and the gross profit before depreciation and taxation Rs. 26.47 crores against Rs. 21.18 crores.

Philips

Philips has posted a net loss of Rs. 6.36 crores for the first quarter ended March 31, 2001, compared to a net loss of Rs. 11.86 crores in same period of previous year. Total income in Q1 was Rs. 346.56 crores as against Rs. 326.58 crores in corresponding period of last year.

According to the company the general slowdown in market particularly in consumer durables and expendables will continue to impact PIL's performance. The management saw 2001 as a year of challenge, it said.

PIL has incurred an expenditure of Rs. 8.55 crores in Q1 on its voluntary retirement scheme, the notice added.

Rolta India

Rolta India has reported a total income of Rs. 80.22 crores in the quarter ended March 31, 2001 against Rs. 58.70 crores in the corresponding period of the previous year, a growth of 36.7 per cent. The cash profit was Rs. 38.15 crores reflecting an operating margin of 47.6 per cent. The net profit after depreciation has risen by 43.7 per cent to Rs. 30.70 crores from Rs. 21.36 crores.

Aptech

Aptech has reported a net profit of Rs. 2.72 crores for the first quarter ended December 31, 2001, an increase of 35.17 per cent over the corresponding period in the previous year. Total global revenues are higher by 21.40 per cent at Rs. 104.28 crores. Of this income from Indian operations is Rs. 66.98 crores and other income Rs. 2.73 crores.

Of the total operating income of Rs. 66.98 crores, the training and education division accounted for Rs. 60.08 crores and the software division Rs. 6.91 crores.

Send this article to Friends by E-Mail


Section  : Business
Previous : SEBI proposals send Sensex reeling
Next     : Cipla to supply anti-AIDS drugs to Nigerian Govt.

Front Page | National | Southern States | Other States | State Elections | International | Opinion | Business | Sport | Miscellaneous | Features | Classifieds | Employment | Index | Home

Copyrights © 2001 The Hindu

Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu